Purification and some properties of kappa toxin of Clostridium perfringens - PubMed (original) (raw)

Purification and some properties of kappa toxin of Clostridium perfringens

S Kameyama et al. Jpn J Med Sci Biol. 1971 Feb.

No abstract available

PubMed Disclaimer

Similar articles

• [Structure and function of Cl. perfringens toxin].
  Ispolatovskaia MV. Ispolatovskaia MV. Vestn Akad Med Nauk SSSR. 1973;28(11):83-9. Vestn Akad Med Nauk SSSR. 1973. PMID: 4132138 Russian. No abstract available.
• Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
  Mitsu K, Mitsui N, Hase J. Mitsu K, et al. Jpn J Exp Med. 1973 Apr;43(2):65-80. Jpn J Exp Med. 1973. PMID: 4352113 No abstract available.
• Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.
  Möllby R, Nord CE, Wadström T. Möllby R, et al. Toxicon. 1973 Feb;11(2):139-47. doi: 10.1016/0041-0101(73)90075-5. Toxicon. 1973. PMID: 4351816 No abstract available.
• Histochemical localization of enzyme activities by substrate film methods: ribonucleases, deoxyribonucleases, proteases, amylase, and hyaluronidase.
  Daoust R. Daoust R. Int Rev Cytol. 1965;18:191-221. doi: 10.1016/s0074-7696(08)60554-9. Int Rev Cytol. 1965. PMID: 5337032 Review. No abstract available.
• [Antigens of Vibrio cholera (review of the literature)].
  Kereselidze TS. Kereselidze TS. Zh Mikrobiol Epidemiol Immunobiol. 1970 May;47(5):60-5. Zh Mikrobiol Epidemiol Immunobiol. 1970. PMID: 4917065 Review. Russian. No abstract available.

Cited by

• Immunoinformatic analysis of the whole proteome for vaccine design: An application to Clostridium perfringens.
  Soto LF, Romaní AC, Jiménez-Avalos G, Silva Y, Ordinola-Ramirez CM, Lopez Lapa RM, Requena D. Soto LF, et al. Front Immunol. 2022 Aug 30;13:942907. doi: 10.3389/fimmu.2022.942907. eCollection 2022. Front Immunol. 2022. PMID: 36110855 Free PMC article.
• Protein Truncating Variants of colA in Clostridium perfringens Type G Strains.
  Van Damme L, Cox N, Callens C, Dargatz M, Flügel M, Hark S, Thiemann F, Pelzer S, Haesebrouck F, Ducatelle R, Van Immerseel F, Goossens E. Van Damme L, et al. Front Cell Infect Microbiol. 2021 Apr 29;11:645248. doi: 10.3389/fcimb.2021.645248. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33996628 Free PMC article.
• Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis.
  Goossens E, Valgaeren BR, Pardon B, Haesebrouck F, Ducatelle R, Deprez PR, Van Immerseel F. Goossens E, et al. Vet Res. 2017 Feb 16;48(1):9. doi: 10.1186/s13567-017-0413-x. Vet Res. 2017. PMID: 28209206 Free PMC article. Review.
• Purification and characterization of Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene.
  Matsushita O, Yoshihara K, Katayama S, Minami J, Okabe A. Matsushita O, et al. J Bacteriol. 1994 Jan;176(1):149-56. doi: 10.1128/jb.176.1.149-156.1994. J Bacteriol. 1994. PMID: 8282691 Free PMC article.
• Bacterial toxins: a table of lethal amounts.
  Gill DM. Gill DM. Microbiol Rev. 1982 Mar;46(1):86-94. doi: 10.1128/mr.46.1.86-94.1982. Microbiol Rev. 1982. PMID: 6806598 Free PMC article. Review. No abstract available.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations